Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242216264 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sein Hwang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Republic of Korea. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Acute Lung Injury, Extracellular Vesicles. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science of ICT, the Ministry of Health & Welfare, South Korea, Ministry of Trade, Industry, and Energy, and the Ministry of Health and Welfare, South Korea, Ministry of Health and Welfare, South Korea.
Abstract (Originalsprache)
Although it has been suggested that toll-like receptor (TLR) 3 and TLR4 activation alters mesenchymal stromal cells (MSCs)’ immunoregulatory function as anti- or pro-inflammatory phenotypes, we have previously confirmed that TLR4-primed hUCB-MSCs alleviate lung inflammation and tissue injury in an E. coli-induced acute lung injury (ALI) mouse model. Therefore, we hypothesized that strong stimulation of TLR3 or TLR4 prompts hUCB-MSCs to exhibit an anti-inflammatory phenotype mediated by extracellular vesicles (EVs). In this study, we compared the anti-inflammatory effect of TLR3-primed and TLR4-primed hUCB-MSCs against an LPS-induced ALI in vitro model by treating MSCs, MSC-derived conditioned medium (CM), and MSC-derived extracellular vesicles (EVs). LPS-induced rat primary alveolar macrophage and RAW 264.7 cells were treated with naïve, TLR3-, and TLR4-primed MSCs and their derived CM and EVs. Flow cytometry and ELISA were used to evaluate M1-M2 polarization of macrophages and pro-inflammatory cytokine levels, respectively. LPS-stimulated macrophages showed significantly increased pro-inflammatory cytokines compared to those of the normal control, and the percentage of M2 macrophage phenotype was predominantly low. In reducing the inflammatory cytokines and enhancing M2 polarization, TLR3- and TLR4-primed MSCs were significantly more effective than the naïve MSCs, and this finding was also observed with the treatment of MSC-derived CMs and EVs. No significant difference between the efficacy of TLR3- and TLR-primed MSCs was observed. Strong stimulation of TLR3- and TLR4-stimulated hUCB-MSCs significantly reduced pro-inflammatory cytokine secretion from LPS-induced macrophages and significantly enhanced the M2 polarization of macrophages. We further confirmed that TLR-primed MSC-derived EVs can exert anti-inflammatory and immunosuppressive effects alone comparable to MSC treatment. We hereby suggest that in the LPS-induced macrophage in vitro model, EVs derived from both TLR3 and TLR4-primed MSCs can be a therapeutic candidate by promoting the M2 phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul 06351, Republic of Korea.
- Cell and Gene Therapy Institute, Samsung Medical Center, Seoul 06351, Republic of Korea.
- Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
ORCID-Profile: Se In Sung, Yun Sil Chang
Förderung
- Ministry of Science of ICT, the Ministry of Health & Welfare, South Korea
- Ministry of Trade, Industry, and Energy, and the Ministry of Health and Welfare, South Korea
- Ministry of Health and Welfare, South Korea
- Samsung Medical Center
- Ministry of Science of ICT
- Ministry of Health and Welfare, Republic of Korea
Zitieren
APA
Hwang, S., Sung, D. K., Kim, Y. E., Yang, M., Ahn, S. Y., Sung, S. I., & Chang, Y. S. (2023). Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216264
Vancouver
Hwang S, Sung DK, Kim YE, Yang M, Ahn SY, Sung SI, et al. Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216264
BibTeX
@article{Hwang2023,
author = {Hwang, Sein and Sung, Dong Kyung and Kim, Young Eun and Yang, Misun and Ahn, So Yoon and Sung, Se In and Chang, Yun Sil},
title = {Mesenchymal Stromal Cells Primed by Toll-like Receptors 3 and 4 Enhanced Anti-Inflammatory Effects against LPS-Induced Macrophages via Extracellular Vesicles},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242216264}
}
EUVIMED